Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, today announced that it granted stock options to Pankaj Bhargava, M.D., the Company’s chief medical officer, on April 16, 2014, including a stock op more

View todays social media effects on DRNA

View the latest stocks trending across Twitter. Click to view dashboard

See who Dicerna is hiring next, click here to view